Company: RGBP
Filing Date: 2025-12-05
Form Type: 253G1
Source: 0001493152-25-026350
Chunk: 135

Company: Regen BioPharma Inc
Filing Date: 2025-12-05
Form: 253G1
Chunk 135
---
 | ) |     |      |         0 |
| Comprehensive Loss                    |     | $                       | (873,102 | ) |     | $    | 1,156,507 |

The accompanying Notes are an integral part of these Financial Statements

<div align='center'>REGEN BIOPHARMA , INC.

CONSOLIDATED STATEMENT OF SHAREHOLDERS’ DEFICIT</div>

|                                                  |     | Series      
 A Preferred |     Shares |     |   | Amount |     |    Series 
        AA 
 Preferred 
    Shares |     |   | Amount |     |    Series 
        NC 
 Preferred 
    Shares |     |   | Amount |     | Common |    Shares |     |   | Amount |     | Series    
 M         
 Preferred | Shares |     |   | Amount |     |   | Additional 
      Paid- 
         in 
    Capital |   |     |   | Accumulated   
 Other         
 Comprehensive 
 Income        |   |     |   | Accumulated 
     Deficit |   |     |   |      Total |   |
|:-------------------------------------------------|:----|:------------|-----------:|:----|:--|-------:|:----|----------:|:----|:--|:-------|:----|----------:|:----|:--|-------:|:----|:-------|----------:|:----|:--|-------:|:----|:----------|-------:|:----|:--|-------:|:----|:--|-----------:|:--|:----|:--|:--------------|:--|:----|:--|------------:|:--|:----|:--|-----------:|:--|
| Balance September 30, 2022                       |     |             |    293,053 |     | $ |     28 |     |        34 |     | $ | -      |     |         7 |     | $ |      - |     |        | 3,354,886 |     | $ |    336 |     |           | 29,338 |     | $ |      3 |     | $ | 12,868,944 |   |     | $ | -             |   |     | $ | (20,905,370 | ) |     | $ | (8,036,059 | ) |
| Preferred Shares Issued for Nonemployee Services |